Informazioni sul prodotto
Nome:
25,26-Dihydroxyvitamin D3
Sinonimi:
- (6R)-2-Methyl-6-[(1R,3aS,4E,7aR)-octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-7a-methyl-1H-inden-1-yl]-1,2-heptanediol
- 1,2-Heptanediol, 2-methyl-6-[(1R,3aS,4E,7aR)-octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-7a-methyl-1H-inden-1-yl]-, (6R)-
- 25,26-Dihydroxycholecalciferol
- 25,26-Dihydroxyvitamin D
- 25,26-Dihydroxyvitamin D<sub>3</sub>
- 29261-12-9
- 9,10-Secocholesta-5,7,10(19)-triene-3,25,26-triol, (3β,5Z,7E)-
- 9,10-Secocholesta-5,7,10(19)-triene-3β,25,26-triol
Descrizione:
25,26-Dihydroxyvitamin D3 is a synthetic product that inhibits the growth of breast cancer cells. This compound is structurally similar to vitamin D3 and has been shown to inhibit the growth of animals with colon cancer. It has also been used in humans to inhibit the growth of breast cancer cells. 25,26-Dihydroxyvitamin D3 inhibits cell proliferation by decreasing the levels of plasma concentrations of hydroxy group and human serum albumin as well as inhibiting protein synthesis in intestinal cells and tubule cells. The effects on these different types of cells may be due to its ability to form isomers with vitamin D3.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
416.64 g/mol
Formula:
C27H44O3
Purezza:
Min. 95%
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
